TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors

T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) expression has been a trending topic in recent years due to its differential expression in a wide range of neoplasms. TIM-3 is one of the key immune checkpoint receptors that interact with GAL-9, PtdSer, HMGB1 and CEACAM1. Initially...

Descripción completa

Detalles Bibliográficos
Autores principales: Sauer, Natalia, Janicka, Natalia, Szlasa, Wojciech, Skinderowicz, Bartłomiej, Kołodzińska, Katarzyna, Dwernicka, Wioletta, Oślizło, Małgorzata, Kulbacka, Julita, Novickij, Vitalij, Karłowicz-Bodalska, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576709/
https://www.ncbi.nlm.nih.gov/pubmed/37567938
http://dx.doi.org/10.1007/s00262-023-03516-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576709/
https://www.ncbi.nlm.nih.gov/pubmed/37567938
http://dx.doi.org/10.1007/s00262-023-03516-1

Ejemplares similares